Post-COVID respiratory management

A review of the literature

The lecture duration is 39min.

0.75 CPD Points, 0.75 CEUs, 0.75 AMA PRA Category 1 Credits.
Accredited by CPDUK, CBRN and EB Medicine.

You can watch this lecture for free! For premium features, including a CPD/CME accredited certificate, to use time-coded note taking or get downloadable slides, you will need a fair price subscription.

Sign In or Sign Up For Free to access this lecture.
Dr Toufic Ahmad Chaaban
Clinical Assistant Professor, Critical Care & Pulmonary Medicine, Lebanese American University
Lecture Summary

COVID19 survivors suffer from persistent respiratory symptoms and functional limitations after the acute infection. Longitudinal studies after SARS-CoV2 infection showed impairment in lung function exercise capacity and Lung imaging abnormalities. In this lecture, we review possible post covid pulmonary involvement with a focus on whether they develop fibrosis. We also review the latest evidence on the long term follow up. Possible treatment strategies are discussed including antifibrotic therapy, mesenchymal cell therapy, prolonged steroids therapy and pulmonary rehabilitation. We conclude with recommendations for pulmonary follow up and post covid clinic design.


There are some minor audio issues during the recording. A new recording is coming soon

Target Audience

Critical Care Doctors
Experienced or advanced Critical Care Nurses

Learning Objectives:

Upon completion of this activity, you should be able to:

  • Review the natural history of lung impairment in previous viral pandemics
  • Understand the spectrum of lung diseases after moderate to severe COVID 19
  • Review the latest evidence on the long-term outcomes after moderate to severe COVID19 infection
  • Understand the rationale and the lack of evidence on antifibrotic treatment
  • Know the importance of pulmonary follow-up and post covid clinics

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of EB Medicine and Continulus. EB Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

EB Medicine designates this internet-enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Needs Assessment

The need for this educational activity was determined by surveys of the target audience and experts in the specialty. Further assessment was provided by examining the topics of recently published evidence-based medicine reviews, national clinical guidelines, and specialty society recommendations, as well as suggestions from evaluations of previous learning programs to determine practice gaps.

CME Faculty Disclosure

It is the policy of EB Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. In compliance with all ACCME accreditation requirements and policies, all faculty for this CME activity were asked to complete a full disclosure statement. The speaker did not report any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) discussed in this educational presentation.

Earning Credit

In order to earn CME credit, the participant must take the pre-test, watch the course, take the CME post-test, and complete the post-test evaluation.

Hardware/Software Requirements

Online learners will need a computer or web-enabled device to access the podcast, additional learning materials, and CME test.

Commercial Support

This activity received no commercial support.